Statistical issues in the use of dynamic allocation methods for balancing baseline covariatesPOND, G. R.British journal of cancer. 2011, Vol 104, Num 11, pp 1711-1715, issn 0007-0920, 5 p.Article

Long-term follow-up of secondary malignancies in adults after allogeneic bone marrow transplantationHASEGAWA, W; POND, G. R; RIFKIND, J. T et al.Bone marrow transplantation (Basingstoke). 2005, Vol 35, Num 1, pp 51-55, issn 0268-3369, 5 p.Article

Cognitive function and fatigue after diagnosis of colorectal cancerVARDY, J; DHILLON, H. M; ZHANG, H et al.Annals of oncology. 2014, Vol 25, Num 12, pp 2404-2412, issn 0923-7534, 9 p.Article

Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancerTOWNSLEY, C. A; MAJOR, P; MOORE, M. J et al.British journal of cancer. 2006, Vol 94, Num 8, pp 1136-1143, issn 0007-0920, 8 p.Article

Gemcitabine concurrent with continuous infusional 5-fluorouracil in advanced biliary cancers: a review of the Princess Margaret Hospital experienceKNOX, J. J; HEDLEY, D; OZA, A et al.Annals of oncology. 2004, Vol 15, Num 5, pp 770-774, issn 0923-7534, 5 p.Article

Tumor factors predictive of response to hypofractionated radiotherapy in a randomized trial following breast conserving therapyBANE, A. L; WHELAN, T. J; POND, G. R et al.Annals of oncology. 2014, Vol 25, Num 5, pp 992-998, issn 0923-7534, 7 p.Article

Translating clinical trials to clinical practice: outcomes of men with metastatic castration resistant prostate cancer treated with docetaxel and prednisone in and out of clinical trialsTEMPLETON, A. J; VERA-BADILLO, F. E; POND, G. R et al.Annals of oncology. 2013, Vol 24, Num 12, pp 2972-2977, issn 0923-7534, 6 p.Article

Correlation of changes between 2-year disease-free survival and 5-year overall survival in adjuvant breast cancer trials from 1966 to 2006NG, R; POND, G. R; TANG, P. A et al.Annals of oncology. 2008, Vol 19, Num 3, pp 481-486, issn 0923-7534, 6 p.Article

Comparison of absolute benefits of anticancer therapies determined by snapshot and area methodsSERUGA, B; POND, G. R; HERTZ, P. C et al.Annals of oncology. 2012, Vol 23, Num 11, pp 2977-2982, issn 0923-7534, 6 p.Article

Survival and PSA response of patients in the TAX 327 study who crossed over to receive docetaxel after mitoxantrone or vice versaBERTHOLD, D. R; POND, G. R; DE WIT, R et al.Annals of oncology. 2008, Vol 19, Num 10, pp 1749-1753, issn 0923-7534, 5 p.Article

Influence of an independent review committee on assessment of response rate and progression-free survival in phase III clinical trialsTANG, P. A; POND, G. R; CHEN, E. X et al.Annals of oncology. 2010, Vol 21, Num 1, pp 19-26, issn 0923-7534, 8 p.Article

A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomasDURAN, I; KORTMANSKY, J; BIRLE, D et al.British journal of cancer. 2006, Vol 95, Num 9, pp 1148-1154, issn 0007-0920, 7 p.Article

Characterisation of the lung toxicity of the cell cycle inhibitor temsirolimusDURAN, I; SIU, L. L; OZA, A. M et al.European journal of cancer (1990). 2006, Vol 42, Num 12, pp 1875-1880, issn 0959-8049, 6 p.Article

Phase I trial of UCN-01 in combination with topotecan in patients with advanced solid cancers : a Princess Margaret Hospital Phase II Consortium studyHOTTE, S. J; OZA, A; WINQUIST, E. W et al.Annals of oncology. 2006, Vol 17, Num 2, pp 334-340, issn 0923-7534, 7 p.Article

Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapyVARDY, J; CHIEW, K. S; GALICA, J et al.British journal of cancer. 2006, Vol 94, Num 7, pp 1011-1015, issn 0007-0920, 5 p.Article

Direct medical costs attributable to osteoporotic fracturesGABRIEL, S. E; TOSTESON, A. N. A; LEIBSON, C. L et al.Osteoporosis international. 2002, Vol 13, Num 4, pp 323-330, issn 0937-941XArticle